RSS

Combating Antibiotic Resistant Bacteria Accelerator (CARB-X)

An affiliate of PureTech Health, Vedanta Biosciences, has been awarded a research grant of up to $5.4 million from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to support clinical testing of its lead product more

News

Clinical-stage biotechnology company, Visterra, has been awarded a research and development contract from the public-private partnership, Combating Antibiotic Resistant Bacteria Accelerator (CARB-X). more

News